This site uses cookies.
Some of these cookies are essential to the operation of the site,
while others help to improve your experience by providing insights into how the site is being used.
For more information, please see the ProZ.com privacy policy.
This person has a SecurePRO™ card. Because this person is not a ProZ.com Plus subscriber, to view his or her SecurePRO™ card you must be a ProZ.com Business member or Plus subscriber.
Euro (eur), Pounds sterling (gbp), U. S. dollars (usd)
Portfolio
Sample translations submitted: 1
English to Swedish: Infectious Mononucleosis General field: Medical Detailed field: Medical (general)
Source text - English Infectious Mononucleosis (IM) is usually a self-limiting disease that is caused by the Epstein-Barr Virus (EBV). The most common symptoms are fatigue, pharyngitis, fever, lymphadenopathy, splenomegaly and hepatitis. In rare cases, complications may develop including severe thrombocytopenia, hemolytic anemia, pericarditis, myocarditis, pneumonitis, Reye’s syndrome, encephalitis and other neurological syndromes. In industrialized countries, the peak incidence of IM occurs between 14 and 18 years of age. In developing or densely populated countries, most children become infected before 3 years of age and symptoms may be mild or clinically inapparent. During the acute phase of illness, certain heterophile antibodies appear in 85–90% of IM cases. These antibodies, known as IM heterophile antibodies, are primarily of the lgM class. IgM to the viral capsid antigen appears early in infection and disappears within 4 to 6 weeks. IgG to the viral capsid antigen appears in the acute phase, peaks at 2 to 4 weeks after onset, declines slightly, and then persists for life. Although the exact mechanism leading to IM heterophile antibody expression has not been determined, the antibodies are specifically associated with the disease. The IM heterophile antibodies are usually demonstrable one week after the onset of illness, peak at two to four weeks, and decline to low levels by 12 weeks. Heterophile antibodies have been detected in patients’ serum over one year after the onset of illness. Reliable laboratory diagnosis of IM has been performed for over fifty years based on the detection of IM heterophile antibodies. These heterophile antibodies are directed against antigens found in bovine, sheep and horse erythrocytes.
Translation - Swedish Infektiös mononukleos (IM) är en vanligen självbegränsande sjukdom som orsakas av Epstein-Barr-virus (EBV). De vanligaste symtomen är trötthet, faryngit, feber, lymfadenopati, splenomegali och hepatit. I ovanliga fall kan komplikationer uppstå, inklusive grav trombocytopeni, hemolytisk anemi, perikardit, myokardit, pneumonit, Reyes syndrom, encefalit och andra neurologiska syndrom. I industrialiserade länder infaller incidenstoppen för IM vid 14 - 18 års ålder. I utvecklingsländer och tättbefolkade länder smittas de flesta barn före 3 års ålder och symtomen kan vara lindriga eller subkliniska. Under sjukdomens akuta fas uppträder vissa heterofila antikroppar i 85–90 % av IM-fallen. Dessa antikroppar, kallade heterofila IM-antikroppar, tillhör huvudsakligen IgM-klassen. IgM mot viralt kapsidantigen uppträder tidigt under infektionen och försvinner inom 4 till 6 veckor. IgG mot viralt kapsidantigen uppträder i den akuta fasen, når sin topp vid 2 till 4 veckor efter debuten, dalar något och kvarstår sedan livet ut. Trots att den exakta mekanism som leder till utryck av heterofila IM-antikroppar inte har fastställts är antikropparna specifikt förknippade med sjukdomen. De heterofila IM-antikropparna kan vanligen påvisas en vecka efter sjukdomsdebuten, når sin topp efter två till fyra veckor och sjunker till låga nivåer efter 12 veckor. Heterofila antikroppar har detekterats i patientserum över ett år efter sjukdomsdebuten. Tillförlitlig laboratoriediagnos av IM, baserad på detektion av heterofila IM-antikroppar, har kunnat utföras i över femtio år. Dessa heterofila antikroppar är riktade mot antigen i erytrocyter från nöt, får och häst.
I translate from English into my native language, Swedish. I specialize in the field of human and veterinary medicine and pharmaceutics and can offer dedication, punctuality and a reliable service. I read a lot in order to keep up-to-date within my fields of expertise.
Education:
– Master of Science in Veterinary Medicine, Swedish University of Agricultural Sciences
– Cell biology and physiology, Medical faculty, Uppsala University, 40 weeks full time studies
– Cambridge Certificate of Proficiency in English, grade A Work experience:
– Clinical work as a veterinarian
– Senior Veterinary Inspector and leading positions at the Swedish National Food Agency
– Freelance translation, editing and proofreading EN>SV since 2007 Recent translations:
Instructions for diagnostic/medical and technical devices, scientific articles for journals, scientific expert reports, SPCs, PILs, material safety data sheets, policy documents, patent applications, web sites CAT tools: Trados Studio 2021, Wordfast, Across
This user has earned KudoZ points by helping other translators with PRO-level terms. Click point total(s) to see term translations provided.
Åsa_Maria K 
